|
|
 |
 |
 |
Genetic Comparison of the Normal,
Infertile and Cancerous Human Testis
Pharmaceutical trial; Thomas
Walsh,
MD, MS
Contact: Sarah Joost, 415/353-7349, sjoost@urology.ucsf.edu
Objectives |
| |
To learn about the genetic basis of infertility and
testis cancer, to characterize the expression of specific
genes that may contribute to infertility and testis cancer.
Three groups of men, normal, infertile, and men with testis
cancer will be studied. |
| |
|
Eligibility |
All patients will undergo
a formal interview and assessments with a physician to determine
their eligibility. |
| |
Men with normal spermatogenesis but no sperm in the
ejaculate because of blockage in the excurrent ducts. Patients
in this group will be men under 50 years old with no known
infertility or testis cancer risk factors. These patients
will have known blockages in the ducts of the reproductive
system from one of the following etiologies: idiopathic
or inflammatory epididymal obstruction, iatrogenic vasal
obstruction (vasectomy, hernia repair), and congenital atresia
or absence of the vas or seminal vesicles. |
| |
Men with a diagnosis of testis cancer who are planning
curative primary surgery with radical orchiectomy. |
| |
Infertile men with no sperm in the ejaculate (azoospermia)
because of spermatogenic failure). These men are <50
years of age and have a history of >1 year of infertility.
A semen analysis demonstrates azoospermia, and a testis
biopsy shows spermatogenic arrest or germ cell absence. |
|
 |
|
 |
|
 |
|